Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.41K Sell
15,173
-25,782
-63% -$22.4K ﹤0.01% 3697
2025
Q4
$48.3K Buy
+40,955
New +$51.8K ﹤0.01% 2840
2025
Q2
Sell
-10,156
Closed -$12.4K 3155
2025
Q1
$12.4K Buy
+10,156
New +$25K ﹤0.01% 2224
2024
Q4
Sell
-12,549
Closed -$31.7K 2924
2024
Q3
$31.7K Sell
12,549
-3,123
-20% -$11.1K ﹤0.01% 1768
2024
Q2
$73.7K Sell
15,672
-17,792
-53% -$93.8K 0.01% 1460
2024
Q1
$190K Buy
+33,464
New +$221K 0.03% 1197

Other funds holding TELA

XTX Topco's TELA Position: Q1 2026 in Review

XTX Topco reduced its TELA Bio (TELA) stake by 63% in Q1 2026, selling an estimated $22.4K and leaving 15,173 shares worth $9.41K. The position accounts for ﹤0.01% of the portfolio, ranked #3697.

XTX Topco first reported a position in TELA in Q1 2024 and has held it in 6 quarters since. The position peaked at $190K in Q1 2024. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • XTX Topco held 15,173 shares of TELA Bio worth $9.41K as of Q1 2026.
  • XTX Topco sold 25,782 TELA Bio shares in Q1 2026, an estimated $22.4K.
  • TELA Bio made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3697 holding.
  • XTX Topco first reported a position in TELA Bio in Q1 2024 and has held it in 6 quarters since.
  • XTX Topco's TELA Bio position peaked at $190K in Q1 2024.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.